Evidence map›Paper›PMID 40985725›Full record

ArticlemBio2025

Extracellular vesicle-mediated delivery of genetic material for transformation and CRISPR/Cas9-based gene editing in

Steven G Sayson, Alan Ashbaugh, Lillian C Bauer, A George Smulian

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mBio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Steven G SaysonDepartment of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.ORCID 0000-0002-7461-0704
Alan AshbaughDepartment of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Lillian C BauerDepartment of Pharmacology, Physiology and Neurobiology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
A George SmulianDepartment of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.ORCID 0000-0003-3272-0697

Funding

Development of a Molecular Toolbox for PneumocystisR61AI187097 · NIAID · UNIVERSITY OF CINCINNATI · PI ALAN George Smulian · 2025 to 2026
$802k
National Institute of Allergy and Infectious Diseases 1R61AI187097NIAID NIH HHS R61 AI187097
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CRISPR-Cas SystemsExtracellular VesiclesGene EditingGene Transfer TechniquesPneumocystisTransformation, GeneticAnimalsLungMicePlasmidsantifungal resistanceCRISPR/Cas9extracellular vesiclesfunctional genomicsgenetic manipulationhomology-directed repairmycologyPneumocystis

Identifiers

PMID40985725
PMCPMC12607567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.